Noesis Capital Mangement Corp lifted its position in Lam Research Corporation (NASDAQ:LRCX - Free Report) by 25.5% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 24,007 shares of the semiconductor company's stock after buying an additional 4,884 shares during the period. Noesis Capital Mangement Corp's holdings in Lam Research were worth $5,129,000 at the end of the most recent reporting period.
Other institutional investors have also modified their holdings of the company. Cedar Mountain Advisors LLC grew its holdings in Lam Research by 242.9% during the first quarter. Cedar Mountain Advisors LLC now owns 120 shares of the semiconductor company's stock worth $26,000 after acquiring an additional 85 shares during the period. Vermillion Wealth Management Inc. acquired a new stake in Lam Research in the 1st quarter valued at about $26,000. PMV Capital Advisers LLC acquired a new stake in Lam Research in the 4th quarter valued at about $25,000. Bayban bought a new position in shares of Lam Research during the 4th quarter valued at about $26,000. Finally, Mcguire Capital Advisors Inc. acquired a new position in shares of Lam Research in the 4th quarter worth approximately $27,000. Institutional investors and hedge funds own 84.61% of the company's stock.
Lam Research Stock Down 3.1%
Shares of Lam Research stock opened at $335.43 on Thursday. Lam Research Corporation has a 1 year low of $90.93 and a 1 year high of $438.50. The company has a market cap of $419.48 billion, a P/E ratio of 63.29, a P/E/G ratio of 2.05 and a beta of 1.80. The company has a current ratio of 2.54, a quick ratio of 1.77 and a debt-to-equity ratio of 0.35. The stock has a 50-day moving average price of $338.50 and a 200 day moving average price of $267.63.
Lam Research (NASDAQ:LRCX - Get Free Report) last released its earnings results on Wednesday, April 22nd. The semiconductor company reported $1.47 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.11. The company had revenue of $5.84 billion for the quarter, compared to analysts' expectations of $5.70 billion. Lam Research had a return on equity of 66.21% and a net margin of 30.94%.The business's revenue for the quarter was up 23.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.04 EPS. Lam Research has set its Q4 2026 guidance at 1.500-1.800 EPS. As a group, analysts expect that Lam Research Corporation will post 5.68 EPS for the current fiscal year.
Lam Research Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Wednesday, July 8th. Investors of record on Wednesday, June 17th were issued a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a dividend yield of 0.3%. The ex-dividend date was Wednesday, June 17th. Lam Research's dividend payout ratio (DPR) is currently 19.62%.
Insider Activity at Lam Research
In other Lam Research news, SVP Neil J. Fernandes sold 18,170 shares of the company's stock in a transaction that occurred on Friday, May 1st. The shares were sold at an average price of $255.14, for a total value of $4,635,893.80. Following the transaction, the senior vice president owned 66,129 shares in the company, valued at approximately $16,872,153.06. This represents a 21.55% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Eric Brandt sold 54,500 shares of the stock in a transaction that occurred on Thursday, June 11th. The stock was sold at an average price of $350.80, for a total transaction of $19,118,600.00. Following the completion of the sale, the director owned 199,205 shares of the company's stock, valued at approximately $69,881,114. The trade was a 21.48% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 104,621 shares of company stock valued at $33,804,737. Company insiders own 0.31% of the company's stock.
Trending Headlines about Lam Research
Here are the key news stories impacting Lam Research this week:
- Positive Sentiment: TD Cowen raised its price target on Lam Research and reiterated a Buy rating, reinforcing the view that the company remains well positioned in the semiconductor equipment cycle. TD Cowen Raises PT on Lam Research (LRCX), Keeps a Buy
- Positive Sentiment: Morgan Stanley listed Lam Research among its top stock picks, citing expectations for strong earnings and continued strength in chip-equipment spending. Buy GE Vernova, Lam Research, United Airlines stocks: Morgan Stanley
- Positive Sentiment: Mizuho lifted its price target on LRCX to $400 from $380 and kept an Outperform rating, saying AI demand should support wafer fab equipment spending for years. Mizuho Raises its Price Target on Lam Research Corporation (LRCX)
- Positive Sentiment: Market commentary continues to point to improving sentiment across semiconductor-equipment names ahead of Lam Research’s late-July earnings report, which is helping buyers step in. Lam Research Rises as Chip-Equipment Sentiment Improves Ahead of Earnings
- Neutral Sentiment: Media coverage from Jim Cramer and others has kept Lam Research in focus, but these stories largely echo the same bullish AI narrative rather than adding new fundamental news. Jim Cramer Shares Why am Research Corporation (LRCX) is on Fire
- Negative Sentiment: One recent headwind is a director sale of 18,282 shares, which can modestly weigh on sentiment even though the transaction was made under a pre-arranged 10b5-1 plan. Lam Research director stock sale
- Negative Sentiment: There is still some near-term caution around semiconductor volatility and cooling AI memory enthusiasm, which could limit upside if capital spending softens. Lam Research (LRCX) Stock Slides As AI Memory Boom Loses Steam
Analyst Upgrades and Downgrades
A number of analysts recently commented on LRCX shares. Wall Street Zen downgraded shares of Lam Research from a "buy" rating to a "hold" rating in a report on Sunday, May 10th. BNP Paribas Exane raised their target price on shares of Lam Research from $250.00 to $260.00 and gave the stock a "neutral" rating in a report on Thursday, April 23rd. Mizuho lifted their price target on shares of Lam Research from $380.00 to $400.00 and gave the stock an "outperform" rating in a research report on Thursday, July 9th. Royal Bank Of Canada upped their price target on Lam Research from $290.00 to $310.00 and gave the company an "outperform" rating in a report on Thursday, April 23rd. Finally, Weiss Ratings downgraded Lam Research from a "buy (b)" rating to a "buy (b-)" rating in a research report on Thursday, May 14th. Twenty-eight research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $358.67.
View Our Latest Stock Analysis on Lam Research
About Lam Research
(
Free Report)
Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Featured Stories
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Lam Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.
While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.